Please assess the completion status of the following clinical trial:

Trial Title: Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Medical history of gastric and/or duodenal ulcer~* A diagnosis of a chronic condition (rheumatoid arthritis, osteoarthritis, lumbago,etc) that requires daily NSAID use,at least 20 years of age~Exclusion Criteria:~* Having gastric or duodenal ulcer in active or healing stage according to the Sakita/Miwa classification~* History of esophageal, gastric or duodenal surgery~* Having severe liver disease or chronic renal disease

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Esomeprazole 20 mg (Type: EXPERIMENTAL): Esomeprazole 20 mg once daily

Based on this trial design, predict the completion outcome and termination type (if applicable).